newsfilter
← Latest News
GlobeNewswire·

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced that President and CEO Athen